A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis

por Cappelli, Laura C., Reed, George, Pappas, Dimitrios A., Kremer, Joel M.
Publicado 2023

Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects

por Giamouzis, Gregory, Pappas, Dimitrios, Simeonidis, Nikolaos, Stathogiannis, Evangelos, Triposkiadis, Filippos, Koukoulis, George N.
Publicado 2010

Synchronous Presence of Nasopharyngeal Carcinoma and Marginal Zone (MALT-Type) B-Cell Lymphoma in the Pharynx

por Koletsa, Triantafyllia, Petrakis, Georgios, Karayannopoulou, Georgia, Pappas, Dimitrios, Markou, Konstantinos, Karkavelas, Georgios, Kostopoulos, Ioannis
Publicado 2011

“Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients”

por Pappas, Dimitrios A, Kremer, Joel M, Reed, George, Greenberg, Jeffrey D, Curtis, Jeffrey R
Publicado 2014

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Blachley, Taylor, Zlotnick, Steve, Best, Jennie, Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2020

TNFi Cycling Versus Changing Mechanism of Action in TNFi‐Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study

por Curtis, Jeffrey R., Kremer, Joel M., Reed, George, John, Ani K., Pappas, Dimitrios A.
Publicado 2021

Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study

por Pappas, Dimitrios A, Giles, Jon T, Connors, Geoffrey, Lechtzin, Noah, Bathon, Joan M, Danoff, Sonye K
Publicado 2010

Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice

por Pappas, Dimitrios A., Etzel, Carol J., Zlotnick, Steve, Best, Jennie, Blachley, Taylor, Kremer, Joel M.
Publicado 2019

Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey

por Pappas, Dimitrios A., Brittle, Christine, Concoff, Andrew, Holman, Andrew J., Takasugi, Dennis, Kremer, Joel M.
Publicado 2022

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Kremer, Joel M., Griffith, Jenny, Reed, George, Salim, Bob, Karki, Chitra, Garg, Vishvas
Publicado 2017

Hydroxychloroquine and the risk of respiratory infections among RA patients

por Kremer, Joel M, Reed, George, Pappas, Dimitrios A, Harold, LR, Kane, Kevin, Greenberg, Jeffrey, Winthrop, Kevin
Publicado 2020

The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry

por Padula, Anthony S., Pappas, Dimitrios A., Fiore, Stefano, Blachley, Taylor S., Ford, Kerri, Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2022

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

por Pappas, Dimitrios A., Brittle, Christine, Mossell, James E., Withers, Johanna B., Lim-Harashima, Jeraldine, Kremer, Joel M.
Publicado 2020

Variable blood processing procedures contribute to plasma proteomic variability

por Halvey, Patrick, Farutin, Victor, Koppes, Laura, Gunay, Nur Sibel, Pappas, Dimitrios A., Manning, Anthony M., Capila, Ishan
Publicado 2021

Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population

por Pappas, Dimitrios A., Reed, George W., Saunders, Katherine, John, Ani, Shewade, Ashwini, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2015

Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry

por Pappas, Dimitrios A., Kent, Jeffrey D., Greenberg, Jeffrey D., Mason, Marc A., Kremer, Joel M., Holt, Robert J.
Publicado 2015

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Blachley, Taylor, Best, Jennie H., Zlotnick, Steve, Reiss, William G., Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2021

Correction to: Giant nonfunctioning adrenal tumors: two case reports and review of the literature

por Chatzoulis, George, Passos, Ioannis, Bakaloudi, Dimitra-Rafailia, Giannakidis, Dimitrios, Koumpoulas, Alexandros, Ioannidis, Konstantinos, Tsifountoudis, Ioannis, Pappas, Dimitrios, Spyridopoulos, Panagiotis
Publicado 2018

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis

por Bergman, Martin J., Kivitz, Alan J., Pappas, Dimitrios A., Kremer, Joel M., Zhang, Lixia, Jeter, Anna, Withers, Johanna B.
Publicado 2020

Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the...

por Pappas, Dimitrios A., O’Brien, Jacqueline, Guo, Lin, Shan, Ying, Baker, Joshua F., Kricorian, Gregory, Stryker, Scott, Collier, David H.
Publicado 2023